Abstract
Pleiotropic effects of therapeutic statins have been frequently reported. The role of p38 MAP kinase has been advanced. In this paper, atorvastatin (containing a terphenylic system), rosuvastatin and fluvastatin, which are important drugs of the statin class, were docked into the active site of p38 MAP kinase where the selective and highly potent inhibitor SB 203580, a fluoro-phenyl pyridinylimidazole derivative, possessing a terphenylic system, binds. The protein-statin complexes near the ATP binding pocket reinforce the hypothesis of p38 MAP kinase as one possible molecular target for statin drugs.
Keywords: Molecular docking, p38 MAP kinase, Pleiotropic effects, Statins
Letters in Drug Design & Discovery
Title: A Theoretical Investigation on the Pleiotropic Effects of Statins as p38 MAP Kinase Ligands
Volume: 7 Issue: 8
Author(s): Carla M.S. Menezes, Carolina M. Avila and Eliezer J. Barreiro
Affiliation:
Keywords: Molecular docking, p38 MAP kinase, Pleiotropic effects, Statins
Abstract: Pleiotropic effects of therapeutic statins have been frequently reported. The role of p38 MAP kinase has been advanced. In this paper, atorvastatin (containing a terphenylic system), rosuvastatin and fluvastatin, which are important drugs of the statin class, were docked into the active site of p38 MAP kinase where the selective and highly potent inhibitor SB 203580, a fluoro-phenyl pyridinylimidazole derivative, possessing a terphenylic system, binds. The protein-statin complexes near the ATP binding pocket reinforce the hypothesis of p38 MAP kinase as one possible molecular target for statin drugs.
Export Options
About this article
Cite this article as:
M.S. Menezes Carla, M. Avila Carolina and J. Barreiro Eliezer, A Theoretical Investigation on the Pleiotropic Effects of Statins as p38 MAP Kinase Ligands, Letters in Drug Design & Discovery 2010; 7 (8) . https://dx.doi.org/10.2174/157018010792062812
DOI https://dx.doi.org/10.2174/157018010792062812 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Phytochemical and Pharmacological Activity Profile of Crataegus oxyacantha L. (Hawthorn) - A Cardiotonic Herb
Current Medicinal Chemistry Drug Repositioning: A Smart Approach for Combating SARS-CoV-2
Anti-Infective Agents Toxicities of Targeted Agents in Advanced Renal Cell Carcinoma
Current Clinical Pharmacology Cytomegalovirus Retinitis Diagnosis and Treatment in a Kidney Transplant Recipient
Infectious Disorders - Drug Targets Microvascular Alterations in Hypertension and Vascular Aging
Current Hypertension Reviews Treatment and Outcome of Pulmonary Arterial Hypertension in HIVInfected Patients: A Review of the Literature
Current HIV Research Dipeptidyl Peptidase IV Inhibitors: A New Paradigm in Type 2 Diabetes Treatment
Current Drug Targets The Proteomic Approach in the Development of Prognostic Biomarkers in Atherothrombosis
Recent Patents on Cardiovascular Drug Discovery Ivabradine: A Current Overview
Current Clinical Pharmacology Patent Selections
Recent Patents on Inflammation & Allergy Drug Discovery Editorial: Oxidative Stress in Pathophysiological Conditions
Current Vascular Pharmacology Secondary Prevention of Ischemic Stroke
Current Drug Targets Critical Illness in Obstetric Patients: Introduction and Epidemiology
Current Women`s Health Reviews Creatine and the Liver: Metabolism and Possible Interactions
Mini-Reviews in Medicinal Chemistry Editorial (Thematic issue: Possible Therapeutic Targets for the Treatment of Diabetic Retinopathy: Evidences from Experimental Models)
Current Clinical Pharmacology Nitric Oxide and Cyclic GMP Signaling Pathway as a Focus for Drug Development
Current Medicinal Chemistry Diabetes and Heart Failure: Is it Hyperglycemia or Hyperinsulinemia?
Current Vascular Pharmacology PDE-5 Inhibitors: Clinical Points
Current Drug Targets Meet Our Regional Editor:
Current Organic Chemistry Mediterranean Diet and Longevity
Current Nutrition & Food Science